SCHEMBL14010649

SCHEMBL14010649

c1ccc(-c2ccccc2N(c2ccc(-c3ccc(N(c4ccccc4-c4ccccc4)c4ccc5c6c(cccc46)-c4ccccc4-5)cc3)cc2)c2ccc3c4c(cccc24)-c2ccccc2-3)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 2/20 0.38
CRHR2 Q13324 2/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
USP2 O75604 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CASP1 P29466 2/20 0.33
HSD17B10 Q99714 2/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
HIF1A Q16665 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 3/20 0.33
PABPC1 P11940 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23546630 0.91 CRHBP (0.42) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL14491574 0.91 CRHBP (0.42) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL14010647 0.91 CRHBP (0.44) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL24254026 0.90 MEN1 (0.32) MEN1KMT2AUSP2
SCHEMBL24254085 0.90 KDM4E (0.38) MEN1KMT2AUSP2MAPK1KDM4E
SCHEMBL23546674 0.89 CRHBP (0.41) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL12566482 0.89 CRHBP (0.41) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL18904410 0.88 CRHBP (0.40) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL24949725 0.88 KDM4E (0.38) CRHBPCRHR2KEAP1NFE2L2MEN1
SCHEMBL5002787 0.88 CRHBP (0.42) CRHBPCRHR2KEAP1NFE2L2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080278065-A1 Organic Electroluminescent Element and Display Apparatus SONY CORPORATION (JP) 2008-11-13 US disclosed
US-20080278065-A1 Organic Electroluminescent Element and Display Apparatus SONY CORPORATION (JP) 2008-11-13 US disclosed
US-20080164809-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS SONY CORPORATION (JP) 2008-07-10 US disclosed
US-20080164809-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS SONY CORPORATION (JP) 2008-07-10 US disclosed
US-20080157657-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY SONY CORPORATION (JP) 2008-07-03 US disclosed
US-20080157657-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY SONY CORPORATION (JP) 2008-07-03 US disclosed
US-20070149815-A1 Organic light-emitting material and method for producing an organic material SONY CORPORATION (JP) 2007-06-28 US disclosed
US-20070149815-A1 Organic light-emitting material and method for producing an organic material SONY CORPORATION (JP) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149815-A1 Organic light-emitting material and method for producing an organic material CRY1, CRY2, IK CRHBP 3880/4885CRHR2 2262/4885KEAP1 1471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.